share_log

科濟藥業-B：截至2024年4月30日止月份之股份發行人的證券變動月報表

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

Hong Kong Stock Exchange ·  May 7 05:33
Summary by Moomoo AI
科濟藥業-B（02171.HK）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股份變動情況。報告顯示，公司法定/註冊股本結存維持在200,000,000,000股，每股面值0.00000025美元，總額為50,000美元，本月無增減變動。根據2019年股權激勵計劃及首次公開發售後購股權計劃，截至4月底，公司可能發行的新股份數量為3,798,492股。本月內無新股份發行，而有233,288股股份期權因失效而被註銷。公司確認，所有發行的證券均已獲得董事會正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
科濟藥業-B（02171.HK）於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年4月30日的公司股份變動情況。報告顯示，公司法定/註冊股本結存維持在200,000,000,000股，每股面值0.00000025美元，總額為50,000美元，本月無增減變動。根據2019年股權激勵計劃及首次公開發售後購股權計劃，截至4月底，公司可能發行的新股份數量為3,798,492股。本月內無新股份發行，而有233,288股股份期權因失效而被註銷。公司確認，所有發行的證券均已獲得董事會正式授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
KOCHI PHARMACEUTICAL-B (02171.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MAY 7, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED APRIL 30, 2024. The report showed that the company's regulated/registered share capital was maintained at 200,000,000,000 shares with a face value of $0.000025 per share for a total of $50,000, with no increase or decrease this month. As of the end of April, the Company may issue 3,798,492 shares under the Equity Incentive Plan 2019 and the Initial Public Offering Possession Option Plan. No new shares were issued during the month and 233,288 share options were cancelled due to expiration. The Company confirms that all securities issued have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
KOCHI PHARMACEUTICAL-B (02171.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MAY 7, 2024, REPORTING THE CHANGES IN COMPANY SHARES FOR THE YEAR ENDED APRIL 30, 2024. The report showed that the company's regulated/registered share capital was maintained at 200,000,000,000 shares with a face value of $0.000025 per share for a total of $50,000, with no increase or decrease this month. As of the end of April, the Company may issue 3,798,492 shares under the Equity Incentive Plan 2019 and the Initial Public Offering Possession Option Plan. No new shares were issued during the month and 233,288 share options were cancelled due to expiration. The Company confirms that all securities issued have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more